AJMC® in the Press, October 7, 2022

An article by Becker's Payer Issues covered a study published in the October 2022 issue of The American Journal of Managed Care^® (AJMC^®). In the study, “Turnover Among New Medicare Advantage Enrollees May Be Greater Than Perceived,” findings revealed that enrollees who join Medicare Advantage undergo significant turnover in the years following enrollment.

Another study published in the AJMC^® October issue, “The Impact of HDHPs on Service Use and Spending for Substance Use Disorders,” was referenced by MedCity News. The study showed that offering a high-deductible health plan (HDHP) led to a 6.6% reduction in the probability of using substance use disorder services and a shift in spending from the plan to the enrollee.

A piece by Health Digest cited an article published on AJMC.com, the website of AJMC^®. The article, “Chemotherapy Demand Will Rise Significantly by 2040, and Workforce Will Need to Expand With It,” indicated that the number of patients requiring first-line chemotherapy is expected to increase by more than 50% from 2018 to 2040.